Manifestations of the mitochondrial A3243G mutation

被引:21
作者
Finsterer, Josef [1 ]
机构
[1] Krankenanstalt Rudolfstiftung Wien, Vienna, Austria
关键词
Mitochondrial disorder; Cardiac involvement; Genetics; Cardiomyopathy; ENCEPHALOPATHY; CARDIOMYOPATHY; PATIENT; MELAS;
D O I
10.1016/j.ijcard.2008.04.089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The tRNA(Leu) A3243G mutation is one of the most frequently observed mutations of mitochondrial DNA genes. Eighty percent of the patients with mitochondrial myopathy, encephalopathy and stroke-like episodes (MELAS) syndrome carry the mutation. Nevertheless, MELAS is genetically heterogeneous and presents with a wide range of phenotypic features. One of the organs most frequently affected is the heart. Cardiac abnormalities manifest as impulse generation or conduction abnormalities or abnormalities of the left ventricular myocardium. To recognize cardiac disease in MELAS thorough and comprehensive investigations are a prerequisite. Early detection of cardiac involvement is essential to punctually treat cardiac disease in MELAS and to prevent sudden cardiac death. Additionally, drugs toxic to the respiratory chain or oxidative phosphorylation need to be avoided. Cardiac affection in MELAS requires special attention since patients may survive malignant rhythm abnormalities or hard failure if detected and treated early. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:60 / 62
页数:4
相关论文
共 14 条
[1]   Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial - Reply [J].
Kaufmann, Petra ;
De Vivo, Darryl .
NEUROLOGY, 2006, 67 (07) :1313-1313
[2]   L-carnitine and neuroprotection in the animal model of mitochrondrial dysfunction [J].
Binienda, Z ;
Przybyla-Zawislak, B ;
Virmani, A ;
Schmued, L .
NEUROPROTECTIVE AGENTS, 2005, 1053 :174-182
[3]   Genetics of hypertrophic cardiomopathy: one, two, or more diseases? [J].
Bos, J. Martijn ;
Ommen, Steve R. ;
Ackerman, Michael J. .
CURRENT OPINION IN CARDIOLOGY, 2007, 22 (03) :193-199
[4]   Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation [J].
Finsterer, J. .
ACTA NEUROLOGICA SCANDINAVICA, 2007, 116 (01) :1-14
[5]   Mitochondriopathies [J].
Finsterer, J .
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (03) :163-186
[6]   Cerebrospinal-fluid lactate in adult mitochondriopathy with and without encephalopathy [J].
Finsterer, J .
ACTA MEDICA AUSTRIACA, 2001, 28 (05) :152-155
[7]   Primary myopathies and the heart [J].
Finsterer, Josef ;
Stoellberger, Claudia .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2008, 42 (01) :9-24
[8]   Anesthetic management for cardioverter-defibrillator implantation in a patient with Kearns-Sayre syndrome [J].
Hara, K ;
Sata, T ;
Shigematsu, A .
JOURNAL OF CLINICAL ANESTHESIA, 2004, 16 (07) :539-541
[9]   Adult-onset hypertrophic cardiomyopathy manifested as initial major presentation of mitochondrial disease with A-to-G 3243 tRNA Leu(UUR) point mutation [J].
Hsu, Po-Chao ;
Chu, Chih-Sheng ;
Lin, Tsung-Hsien ;
Lu, Ye-Hsu ;
Lee, Chee-Siong ;
Lai, Wen-Ter ;
Sheu, Sheng-Hsiung .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 129 (03) :441-443
[10]   MELAS and L-arginine therapy [J].
Koga, Yasutoshi ;
Akita, Yukhiro ;
Nishioka, Junko ;
Yatsuga, Shuichi ;
Povalko, Nataliya ;
Katayama, Koujyu ;
Matsuishi, Toyojiro .
MITOCHONDRION, 2007, 7 (1-2) :133-139